Yingshi Chen

Yingshi Chen

Auto-generated profile, based on publicly available information

Yingshi Chen

Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2024 in Nature
Verified
Journal Article
Open access
PDF file
ADAlexander E. Doan
Alexander E. Doan
KMKatherine P. Mueller
Katherine P. Mueller
ACAndy Y. Chen
Andy Y. Chen
GRGeoffrey T. Rouin
Geoffrey T. Rouin
YCYingshi Chen
Yingshi Chen
EWEvan W. Weber
Evan W. Weber
A major limitation of chimeric antigen receptor (CAR) T cell therapies is the poor persistence of these cells in vivo1. The expression of memory-associated genes in CAR T cells is linked to their long-term persistence in patients and clinical efficacy2–6, suggesting that memory programs may underpin durable CAR T cell function. Here we show that the transcription factor FOXO1 is responsible for promoting memory and restraining exhaustion in human CAR T cells. Pharmacological inhibition or gene editing of endogenous FOXO1 diminished the expression of memory-associated genes, promoted an exhaustion-like phenotype and impaired the antitumour activity of CAR T cells. Overexpression of FOXO1 induced a gene-expression program consistent with T cell memory and increased chromatin accessibility at FOXO1-binding motifs. CAR T cells that overexpressed FOXO1 retained their function, memory potential and metabolic fitness in settings of chronic stimulation, and exhibited enhanced persistence and tumour control in vivo. By contrast, overexpression of TCF1 (encoded by TCF7) did not enforce canonical memory programs or enhance the potency of CAR T cells. Notably, FOXO1 activity correlated with positive clinical outcomes of patients treated with CAR T cells or tumour-infiltrating lymphocytes, underscoring the clinical relevance of FOXO1 in cancer immunotherapy. Our results show that overexpressing FOXO1 can increase the antitumour activity of human CAR T cells, and highlight memory reprogramming as a broadly applicable approach for optimizing therapeutic T cell states.

23 April 2024 in Nature
Verified
Journal Article
Open access
PDF file
ADAlexander E. Doan
Alexander E. Doan
KMKatherine P. Mueller
Katherine P. Mueller
ACAndy Y. Chen
Andy Y. Chen
GRGeoffrey T. Rouin
Geoffrey T. Rouin
YCYingshi Chen
Yingshi Chen
EWEvan W. Weber
Evan W. Weber

7 November 2023 in Research Square
Verified
Preprint
Open access
PDF file
CMCrystal Mackall
Crystal Mackall
ADAlexander Doan
Alexander Doan
KMKatherine Mueller
Katherine Mueller
ACAndy Chen
Andy Chen
GRGeoffrey Rouin
Geoffrey Rouin
EWEvan Weber
Evan Weber
Poor CAR T persistence limits CAR T cell therapies for B cell malignancies and solid tumors1,2. The expression of memory-associated genes such as TCF7 (protein name TCF1) is linked to response and long-term persistence in patients3-7, thereby implicating memory programs in therapeutic efficacy. Here, we demonstrate that the pioneer transcription factor, FOXO1, is responsible for promoting memory programs and restraining exhaustion in human CAR T cells. Pharmacologic inhibition or gene editing of endogenous FOXO1 in human CAR T cells diminished the expression of memory-associated genes, promoted an exhaustion-like phenotype, and impaired antitumor activity in vitro and in vivo. FOXO1 overexpression induced a gene expression program consistent with T cell memory and increased chromatin accessibility at FOXO1 binding motifs. FOXO1-overexpressing cells retained function, memory potential, and metabolic fitness during settings of chronic stimulation and exhibited enhanced persistence and antitumor activity in vivo. Paradoxically, TCF1 overexpression failed to enforce canonical memory programs or enhance CAR T cell potency. Importantly, endogenous FOXO1 activity correlated with CAR T and TIL responses in patients, underscoring its clinical relevance in cancer immunotherapy. Our results demonstrate that memory reprogramming through FOXO1 can enhance the persistence and potency of human CAR T cells and highlights the utility of pioneer factors, which bind condensed chromatin and induce local epigenetic remodeling, for optimizing therapeutic T cell states.

1 January 2021 in arXiv
Verified
Preprint
Open access
PDF file
YCYingshi Chen
Yingshi Chen
Kronecker-factored Approximate Curvature (K-FAC) method is a high efficiency second order optimizer for the deep learning. Its training time is less than SGD(or other first-order method) with same accuracy in many large-scale problems. The key of K-FAC is to approximates Fisher information matrix (FIM) as a block-diagonal matrix where each block is an inverse of tiny Kronecker factors. In this short note, we present CG-FAC -- an new iterative K-FAC algorithm. It uses conjugate gradient method to approximate the nature gradient. This CG-FAC method is matrix-free, that is, no need to generate the FIM matrix, also no need to generate the Kronecker factors A and G. We prove that the time and memory complexity of iterative CG-FAC is much less than that of standard K-FAC algorithm.